Lonapegsomatropin Provides Height Improvements in Later Tanner Stages without Increase in Dose

Lonapegsomatropin, a once-weekly prodrug of somatropin, can help children in Tanner Stages 3-5 maintain consistent height standard deviation scores (SDS) without an increase in the mean dose, according to a study presented at ENDO 2023. Ascendis Pharma is marketing the drug as TransCon hGH. Researchers led by Paul Hofman, MD, FRACP, of the Liggins Institute […]

To view the full Member Resource, please Log in


TOPICS IN THIS ARTICLE:


Share this article